NASDAQ:TNYA

Tenaya Therapeutics Stock Insider Trading

etoro logo Buy TNYA
*Your capital is at risk
$0.731
+0.0191 (+2.68%)
At Close: Jun 18, 2026

Tenaya Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 83.54. In total, the insiders bought 147.1M and sold 7.89M TNYA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
83.54
Buy 147.1M shares
Sell 7.89M shares
34% Buy Activity
Weak Negative Correlation
Sell Signal Low Confidence
Feb 25, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 83.54.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Aug 18, 2025
Sell
Common Stock
S-Sale
Ali Faraz
Chief Executive Officer
CEO / President 5 720
Value: $7K
Aug 18, 2025
Sell
Common Stock
S-Sale
Tingley Whittemore
Chief Medical Officer
Officer 1 837
Value: $2K
Aug 18, 2025
Sell
Common Stock
S-Sale
Tingley Whittemore
Chief Medical Officer
Officer 1 608
Value: $2K
Aug 18, 2025
Sell
Common Stock
S-Sale
Tingley Whittemore
Chief Medical Officer
Officer 1 608
Value: $2K
Aug 18, 2025
Sell
Common Stock
S-Sale
Higa Tomohiro
SVP, Finance
Officer 1 722
Value: $2K
Aug 18, 2025
Sell
Common Stock
S-Sale
Higa Tomohiro
SVP, Finance
Officer 717
Value: $898
Aug 18, 2025
Sell
Common Stock
S-Sale
Higa Tomohiro
SVP, Finance
Officer 523
Value: $655
May 29, 2025
Buy
Stock Option (Right to buy)
A-Award
Stehman-breen Catherine
Director
Director 107 400
Value: $47.7K
May 29, 2025
Buy
Stock Option (Right to buy)
A-Award
Walsh Jeffrey T.
Director
Director 107 400
Value: $47.7K
May 29, 2025
Buy
Stock Option (Right to buy)
A-Award
Burroughs Amy L.
Director
Director 107 400
Value: $47.7K
May 29, 2025
Buy
Stock Option (Right to buy)
A-Award
Goeddel David V
Director 107 400
Value: $47.7K
May 29, 2025
Buy
Stock Option (Right to buy)
A-Award
Williams R Sanders
Director
Director 107 400
Value: $47.7K
May 29, 2025
Buy
Stock Option (Right to buy)
A-Award
Srivastava Deepak
Director
Director 107 400
Value: $47.7K
May 29, 2025
Buy
Stock Option (Right to buy)
A-Award
Lee June
Director
Director 107 400
Value: $47.7K
May 29, 2025
Buy
Stock Option (Right to buy)
A-Award
Parschauer Karah Herdman
Director
Director 107 400
Value: $47.7K
May 29, 2025
Buy
Stock Option (Right to buy)
A-Award
Parschauer Karah Herdman
Director
Director 107 400
Value: $47.7K
May 29, 2025
Buy
Stock Option (Right to buy)
A-Award
Lee June
Director
Director 107 400
Value: $47.7K
May 29, 2025
Buy
Stock Option (Right to buy)
A-Award
Srivastava Deepak
Director
Director 107 400
Value: $47.7K
May 29, 2025
Buy
Stock Option (Right to buy)
A-Award
Williams R Sanders
Director
Director 107 400
Value: $47.7K
May 29, 2025
Buy
Stock Option (Right to buy)
A-Award
Goeddel David V
Director 107 400
Value: $47.7K
May 29, 2025
Buy
Stock Option (Right to buy)
A-Award
Burroughs Amy L.
Director
Director 107 400
Value: $47.7K
May 29, 2025
Buy
Stock Option (Right to buy)
A-Award
Walsh Jeffrey T.
Director
Director 107 400
Value: $47.7K
May 29, 2025
Buy
Stock Option (Right to buy)
A-Award
Stehman-breen Catherine
Director
Director 107 400
Value: $47.7K
May 16, 2025
Sell
Common Stock
S-Sale
Higa Tomohiro
SVP, Finance
Officer 1 390
Value: $615
May 16, 2025
Sell
Common Stock
S-Sale
Tingley Whittemore
Chief Medical Officer
Officer 2 937
Value: $1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT TENAYA THERAPEUTICS, INC.
Tenaya Therapeutics
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hypertrophic cardiomyopathy (gHCM) caused by haploinsufficient myosin binding protein C3 (MYBPC3) gene mut...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE